FDA Approved: EVEKEO — Supplemental Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for EVEKEO, a brand-name amphetamine sulfate product from Azurity Pharmaceuticals, under ANDA 200166.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Narcolepsy

Drugs mentioned

• EVEKEO (AMPHETAMINE SULFATE)

Snippet

SUPPL AP for EVEKEO (AMPHETAMINE SULFATE)